[
    {
        "page": 1,
        "paragraphs": "OLSC PRV PRIMARY CARE Melvin, William F 1541 Kings Hwy MRN: 14458325, DOB: 9/24/1948, Legal Sex: M SHREVEPORT LA 71103-4228 Acct #: 28009157410 Enc. Date 10/9/2024 10/09/2024 - Office Visit in Shreveport-Provenance Primary Care Diagnoses Codes Comments Hyperlipidemia, unspecified hyperlipidemia type - Primary ICD-10-CM: E78.5 ICD-9-CM: 272.4 Type 2 diabetes mellitus with diabetic microalbuminuria, without long-term ICD-10-CM: E11.29, current use of insulin R80.9 ICD-9-CM: 250.40, 791.0 Problem List as of 10/9/2024 Date Reviewed: 4/9/2024 Codes Priority Class Noted - Resolved History of herpes zoster ICD-10-CM: Z86.19 12/31/1977 - ICD-9-CM: V12.09 Present Type 2 diabetes mellitus ICD-10-CM: E11.9 1/1/1999 - Present ICD-9-CM: 250.00 History of colonic polyps ICD-10-CM: Z86.0100 12/31/2013 - ICD-9-CM: V12.72 Present Overview Signed 7/3/2023 8:12 AM by Callegan-Poche, Amanda L., MD Removal Reason: removed Lipoma of forearm ICD-10-CM: D17.20 10/1/2016 - ICD-9-CM: 214.1 Present Overview Signed 7/3/2023 8:12 AM by Callegan-Poche, Amanda L., MD surgical removal Removal Reason: surgical removal Contracture of skin of hand ICD-10-CM: L98.8 11/30/2016 - ICD-9-CM: 709.8 Present Overview Signed 7/3/2023 8:12 AM by Callegan-Poche, Amanda L., MD Depuytrens left hand Nephropathy due to secondary diabetes ICD-10-CM: E13.21 6/7/2021 - Present mellitus ICD-9-CM: 249.40, 583.81 Ophthalmic herpes simplex ICD-10-CM: B00.50 10/27/2021 - ICD-9-CM: 054.40 Present Overview Signed 7/3/2023 8:12 AM by Callegan-Poche, Amanda L., MD (10/2021) right eye Diverticular disease ICD-10-CM: K57.90 8/17/2022 - ICD-9-CM: 562.10 Present Hyperlipidemia ICD-10-CM: E78.5 8/17/2022 - ICD-9-CM: 272.4 Present Hypertensive disorder ICD-10-CM: I10 8/17/2022 - ICD-9-CM: 401.9 Present Ulcerative proctocolitis ICD-10-CM: K51.30 8/17/2022 - ICD-9-CM: 556.2 Present RESOLVED: Bilateral tinnitus ICD-10-CM: H93.13 1/1/2003 - ICD-9-CM: 388.30 8/17/2022 Patient as-of Visit Allergies as of 10/9/2024 Allergies last reviewed by Callegan-Poche, Amanda L., MD on 4/9/2024 1041 No Known Allergies Immunizations as of 10/9/2024 Immunization Date Generated on 10/30/24 11:39 AM Page 1"
    },
    {
        "page": 2,
        "paragraphs": "OLSC PRV PRIMARY CARE Melvin, William F 1541 Kings Hwy MRN: 14458325, DOB: 9/24/1948, Legal Sex: M SHREVEPORT LA 71103-4228 Acct #: 28009157410 Enc. Date 10/9/2024 10/09/2024 - Office Visit in Shreveport-Provenance Primary Care (continued) Patient as-of Visit (continued) COVID-19, vector-nr, rS-Ad26, PF (Janssen) 03/20/2021, 12/24/2021 Influenza (FLUAD) - Quadrivalent - Adjuvanted - PF *Preferred* 10/24/2022, 11/16/2023 (65+) Influenza - Trivalent - Afluria, Fluzone MDV 09/13/2018 Pneumococcal Conjugate - 20 Valent 11/29/2022 Tdap 01/01/2016 Outpatient Medications at Start of Encounter as of 10/9/2024 Disp Refills Start End aspirin 81 MG Chew (Taking) — — — Sig - Route: Take 2 tablets by mouth once daily. - Oral Class: Historical Med cetirizine (ZYRTEC) 10 MG tablet (Taking) 90 tablet 1 4/8/2024 — Sig - Route: Take 1 tablet (10 mg total) by mouth once daily. - Oral empagliflozin (JARDIANCE) 25 mg tablet (Taking) 90 tablet 1 4/8/2024 — Sig - Route: Take 1 tablet (25 mg total) by mouth once daily. - Oral Notes to Pharmacy: DX Code E11.9 ezetimibe (ZETIA) 10 mg tablet (Taking) 90 tablet 0 8/16/2024 — Sig - Route: TAKE 1 TABLET BY MOUTH EVERY DAY - Oral fosinopriL (MONOPRIL) 20 MG tablet (Taking) 90 tablet 3 4/8/2024 — Sig - Route: Take 1 tablet (20 mg total) by mouth once daily. - Oral gabapentin (NEURONTIN) 300 MG capsule (Taking) 90 capsule 0 6/29/2023 — Sig - Route: Take 1 capsule (300 mg total) by mouth 3 (three) times daily. - Oral glipiZIDE (GLUCOTROL) 10 MG TR24 (Taking) 180 tablet 1 4/9/2024 — Sig - Route: Take 1 tablet (10 mg total) by mouth 2 (two) times daily with meals. - Oral mesalamine (CANASA) 1000 MG Supp (Taking) 90 suppository 1 4/8/2024 — Sig - Route: Place 1 suppository (1,000 mg total) rectally nightly. - Rectal rosuvastatin (CRESTOR) 40 MG Tab (Taking) 90 tablet 1 4/8/2024 — Sig - Route: Take 1 tablet (40 mg total) by mouth once daily. - Oral SITagliptan-metformin (JANUMET) 50-1,000 mg per 180 tablet 3 4/16/2024 4/16/2025 tablet (Taking) Sig - Route: Take 1 tablet by mouth 2 (two) times daily with meals. - Oral Medications the Patient Reported Taking Disp Refills Start End aspirin 81 MG Chew (Taking) — — — Sig: Take 2 tablets by mouth once daily. Class: Historical Med Route: Oral cetirizine (ZYRTEC) 10 MG tablet (Taking) 90 tablet 1 4/8/2024 — Sig: Take 1 tablet (10 mg total) by mouth once daily. Route: Oral empagliflozin (JARDIANCE) 25 mg tablet (Taking) 90 tablet 1 4/8/2024 — Sig: Take 1 tablet (25 mg total) by mouth once daily. Notes to Pharmacy: DX Code E11.9 Route: Oral ezetimibe (ZETIA) 10 mg tablet (Taking) 90 tablet 0 8/16/2024 — Sig: TAKE 1 TABLET BY MOUTH EVERY DAY Route: Oral fosinopriL (MONOPRIL) 20 MG tablet (Taking) 90 tablet 3 4/8/2024 — Sig: Take 1 tablet (20 mg total) by mouth once daily. Route: Oral gabapentin (NEURONTIN) 300 MG capsule (Taking) 90 capsule 0 6/29/2023 — Sig: Take 1 capsule (300 mg total) by mouth 3 (three) times daily. Route: Oral glipiZIDE (GLUCOTROL) 10 MG TR24 (Taking) 180 tablet 1 4/9/2024 — Sig: Take 1 tablet (10 mg total) by mouth 2 (two) times daily with meals. Route: Oral Generated on 10/30/24 11:39 AM Page 2"
    },
    {
        "page": 3,
        "paragraphs": "OLSC PRV PRIMARY CARE Melvin, William F 1541 Kings Hwy MRN: 14458325, DOB: 9/24/1948, Legal Sex: M SHREVEPORT LA 71103-4228 Acct #: 28009157410 Enc. Date 10/9/2024 10/09/2024 - Office Visit in Shreveport-Provenance Primary Care (continued) Medications the Patient Reported Taking (continued) Disp Refills Start End mesalamine (CANASA) 1000 MG Supp (Taking) 90 suppository 1 4/8/2024 — Sig: Place 1 suppository (1,000 mg total) rectally nightly. Route: Rectal rosuvastatin (CRESTOR) 40 MG Tab (Taking) 90 tablet 1 4/8/2024 — Sig: Take 1 tablet (40 mg total) by mouth once daily. Route: Oral SITagliptan-metformin (JANUMET) 50-1,000 mg per 180 tablet 3 4/16/2024 4/16/2025 tablet (Taking) Sig: Take 1 tablet by mouth 2 (two) times daily with meals. Route: Oral Progress Notes Progress Notes by Callegan-Poche, Amanda L., MD at 10/9/2024 8:15 AM Author: Callegan-Poche, Amanda L., MD Service: — Author Type: Physician Filed: 10/9/2024 1:17 PM Encounter Date: 10/9/2024 Creation Time: 10/9/2024 8:31 AM Status: Sign when Signing Visit Editor: Callegan-Poche, Amanda L., MD (Physician) Ochsner-LSU Health | Provenance Primary Care - Amanda Callegan-Poche', MD Legal Name: William F Melvin Preferred Name: William F Melvin DOB: 9/24/1948 MRN: 14458325 Date: 10/9/24 No chief complaint on file. History of Present Illness William F Melvin is a 76 y.o. White male who presents today for follow-up of chronic medical conditions. He denies any acute concerns or recent illnesses. The patient reports compliance with his medications. He denies any medication side effects. Janumet - Jardiance - Walmart Eye Exam maybe 4 months ago The patient presents today with no specific chief complaint. He denies any concerns or problems with his medications. He reports checking his blood pressure at home and is mainly focused on his A1c levels. The patient admits to not checking his blood sugars regularly. He mentions walking two miles daily for the past six to eight months. The patient declines a flu shot and has not seen an eye doctor this year. He experiences occasional dizziness, particularly after consuming sugary foods like cake, but denies any trouble breathing, new rashes, skin lesions, or vision changes. Generated on 10/30/24 11:39 AM Page 3"
    },
    {
        "page": 4,
        "paragraphs": "OLSC PRV PRIMARY CARE Melvin, William F 1541 Kings Hwy MRN: 14458325, DOB: 9/24/1948, Legal Sex: M SHREVEPORT LA 71103-4228 Acct #: 28009157410 Enc. Date 10/9/2024 Progress Notes (continued) Progress Notes by Callegan-Poche, Amanda L., MD at 10/9/2024 8:15 AM (continued) The patient confirms that he is still taking all of his prescribed medications and discusses concerns about medication refills and insurance caps for the upcoming year. He believes he had a retinopathy screen done at an eye exam approximately four months ago but is unsure if the results were sent to the clinic. Review of Systems Review of Systems Constitutional: Negative for chills and fever. Eyes: Negative for visual disturbance. Respiratory: Negative for shortness of breath and stridor. Cardiovascular: Negative for chest pain and leg swelling. Gastrointestinal: Negative for constipation, diarrhea, nausea and vomiting. Musculoskeletal: Negative for gait problem. Skin: Negative for rash. Neurological: Positive for dizziness (when eating increased sugar). Negative for syncope and light-headedness. Medical / Social / Family History Past Medical History: Diagnosis Date •Diabetes mellitus, type 2 •Hyperlipidemia •Hypertension No past surgical history on file. Social History Tobacco Use •Smoking status: Never Passive exposure: Never •Smokeless tobacco: Never Substance Use Topics •Alcohol use: Yes Comment: social •Drug use: Never No family history on file. Medications and Allergies Current Outpatient Medications Medication Sig Dispense Refill •aspirin 81 MG Chew Take 2 tablets by mouth once daily. Generated on 10/30/24 11:39 AM Page 4"
    },
    {
        "page": 5,
        "paragraphs": "OLSC PRV PRIMARY CARE Melvin, William F 1541 Kings Hwy MRN: 14458325, DOB: 9/24/1948, Legal Sex: M SHREVEPORT LA 71103-4228 Acct #: 28009157410 Enc. Date 10/9/2024 Progress Notes (continued) Progress Notes by Callegan-Poche, Amanda L., MD at 10/9/2024 8:15 AM (continued) •cetirizine (ZYRTEC) 10 MG Take 1 tablet (10 mg 90 tablet 1 tablet total) by mouth once daily. •empagliflozin (JARDIANCE) 25 Take 1 tablet (25 mg 90 tablet 1 mg tablet total) by mouth once daily. •ezetimibe (ZETIA) 10 mg tablet TAKE 1 TABLET BY 90 tablet 0 MOUTH EVERY DAY •fosinopriL (MONOPRIL) 20 MG Take 1 tablet (20 mg 90 tablet 3 tablet total) by mouth once daily. •gabapentin (NEURONTIN) 300 Take 1 capsule (300 90 capsule 0 MG capsule mg total) by mouth 3 (three) times daily. •glipiZIDE (GLUCOTROL) 10 Take 1 tablet (10 mg 180 tablet 1 MG TR24 total) by mouth 2 (two) times daily with meals. •mesalamine (CANASA) 1000 Place 1 suppository 90 1 MG Supp (1,000 mg total) suppository rectally nightly. •rosuvastatin (CRESTOR) 40 Take 1 tablet (40 mg 90 tablet 1 MG Tab total) by mouth once daily. •SITagliptan-metformin Take 1 tablet by 180 tablet 3 (JANUMET) 50-1,000 mg per mouth 2 (two) times tablet daily with meals. No current facility-administered medications for this visit. Review of patient's allergies indicates: No Known Allergies Physical Examination Vitals: 10/09/24 0823 BP: 133/63 Pulse: 62 Resp: 16 SpO2: (!) 94% Weight: 84.6 kg (186 lb 9.6 oz) Body mass index is 27.56 kg/m². Physical Exam Health Maintenance / Imaging / Labs Generated on 10/30/24 11:39 AM Page 5"
    },
    {
        "page": 6,
        "paragraphs": "OLSC PRV PRIMARY CARE Melvin, William F 1541 Kings Hwy MRN: 14458325, DOB: 9/24/1948, Legal Sex: M SHREVEPORT LA 71103-4228 Acct #: 28009157410 Enc. Date 10/9/2024 Progress Notes (continued) Progress Notes by Callegan-Poche, Amanda L., MD at 10/9/2024 8:15 AM (continued) Health Maintenance Date Due Completion Date Eye Exam Never done --- Shingles Vaccine (1 of 2) Never done --- RSV Vaccine (Age 60+ and Pregnant Never done --- patients) (1 - 1-dose 75+ series) Diabetes Urine Screening 07/03/2024 7/3/2023 Lipid Panel 07/03/2024 7/3/2023 Hemoglobin A1c 07/08/2024 4/8/2024 Influenza Vaccine (1) 09/01/2024 11/16/2023 COVID-19 Vaccine (3 - 2024-25 season) 09/01/2024 12/24/2021 TETANUS VACCINE 01/01/2026 1/1/2016 Lab Results Component Value Date HGBA1C 8.1 (H) 04/08/2024 HGBA1C 7.9 (H) 10/04/2023 Lab Results Component Value Date MICALBCREAT 31.0 (H) 07/03/2023 No results found for: \"LIPIDTOTCHOL\", \"LIPIDLDLCHOL\", \"LIPIDHDLCHOL\", \"LIPIDTRIG\" No results found for: \"VITAMIND25HY\" Lab Results Component Value Date BUN 18 04/08/2024 CREATININE 0.8 04/08/2024 AST 28 04/08/2024 ALT 36 04/08/2024 Assessment William F Melvin is a 76 y.o. White male seen at Ochsner LSU Health Provenance Primary Care outpatient clinic for *** Plan *** This note was transcribed in part, using a voice recognition system (M-modal). Grammatical and content errors may have inadvertently been generated. Please review within this context and contact this physician if you find or perceive Generated on 10/30/24 11:39 AM Page 6"
    },
    {
        "page": 7,
        "paragraphs": "OLSC PRV PRIMARY CARE Melvin, William F 1541 Kings Hwy MRN: 14458325, DOB: 9/24/1948, Legal Sex: M SHREVEPORT LA 71103-4228 Acct #: 28009157410 Enc. Date 10/9/2024 Progress Notes (continued) Progress Notes by Callegan-Poche, Amanda L., MD at 10/9/2024 8:15 AM (continued) inappropriate information in the report. No future appointments. Amanda Callegan-Poche', MD Internal Medicine-Pediatrics Ochsner LSU Health Provenance Primary Care 10/9/24 Labs Hemoglobin A1C [1096741731] (Final result) Electronically signed by: Callegan-Poche, Amanda L., MD on 10/09/24 0834 Status: Completed Ordering user: Callegan-Poche, Amanda L., MD 10/09/24 0834 Authorized by: Callegan-Poche, Amanda L., MD Ordering mode: Standard Frequency: Routine 10/09/24 - Class: Clinic Collect Quantity: 1 Lab status: Final result Diagnoses Type 2 diabetes mellitus with diabetic microalbuminuria, without long-term current use of insulin [E11.29, R80.9] Specimen Information ID Type Draw Type Source Collected By 24OLSH- Blood Venipuncture Blood Brown, Shaquerra, CMA 283C0337 10/09/24 0846 Hemoglobin A1C [1096741731] (Abnormal) Resulted: 10/09/24 2003, Result status: Final result Order status: Completed Filed by: Lab, Background User 10/09/24 2003 Collected by: Brown, Shaquerra, CMA 10/09/24 0846 Resulting lab: OCHSNER LSU HEALTH SHREVEPORT Components Component Value Reference Range Flag Lab Hemoglobin A1c 7.6 4.0 - 5.6 % H SHVRT Comment: ADA Screening Guidelines: 5.7-6.4% Consistent with prediabetes >=6.5% Consistent with diabetes High levels of fetal hemoglobin interfere with the HbA1C assay. Heterozygous hemoglobin variants (HbS, HgC, etc)do not significantly interfere with this assay. However, presence of multiple variants may affect accuracy. Estimated Average Glucose 171 68 - 131 mg/dL H SHVRT Testing Performed By Lab - Abbreviation Name Director Address Valid Date Range 650 - SHVRT OCHSNER LSU Unknown 1541 Kings Hwy 04/27/23 0824 - Present HEALTH SHREVEPORT LA SHREVEPORT 71103 Indications Type 2 diabetes mellitus with diabetic microalbuminuria, without long-term current use of insulin [E11.29, R80.9 (ICD-10-CM)] Generated on 10/30/24 11:39 AM Page 7"
    },
    {
        "page": 8,
        "paragraphs": "OLSC PRV PRIMARY CARE Melvin, William F 1541 Kings Hwy MRN: 14458325, DOB: 9/24/1948, Legal Sex: M SHREVEPORT LA 71103-4228 Acct #: 28009157410 Enc. Date 10/9/2024 Labs (continued) Lipid Panel [1096741732] (Final result) Electronically signed by: Callegan-Poche, Amanda L., MD on 10/09/24 0834 Status: Completed Ordering user: Callegan-Poche, Amanda L., MD 10/09/24 0834 Authorized by: Callegan-Poche, Amanda L., MD Ordering mode: Standard Frequency: Routine 10/09/24 - Class: Clinic Collect Quantity: 1 Lab status: Final result Diagnoses Type 2 diabetes mellitus with diabetic microalbuminuria, without long-term current use of insulin [E11.29, R80.9] Specimen Information ID Type Draw Type Source Collected By 24OLSH- Blood Venipuncture Blood Brown, Shaquerra, CMA 283C0336 10/09/24 0846 Lipid Panel [1096741732] (Abnormal) Resulted: 10/09/24 1956, Result status: Final result Order status: Completed Filed by: Lab, Background User 10/09/24 1956 Collected by: Brown, Shaquerra, CMA 10/09/24 0846 Resulting lab: OCHSNER LSU HEALTH SHREVEPORT Components Component Value Reference Range Flag Lab Cholesterol Total 100 120 - 199 mg/dL L SHVRT Comment: The National Cholesterol Education Program (NCEP) has set the following guidelines (reference ranges) for Cholesterol: Optimal.....................<200 mg/dL Borderline High.............200-239 mg/dL High........................> or = 240 mg/dL Triglyceride 262 30 - 150 mg/dL H SHVRT Comment: The National Cholesterol Education Program (NCEP) has set the following guidelines (reference values) for triglycerides: Normal......................<150 mg/dL Borderline High.............150-199 mg/dL High........................200-499 mg/dL HDL Cholesterol 25 40 - 75 mg/dL L SHVRT Comment: The National Cholesterol Education Program (NCEP) has set the following guidelines (reference values) for HDL Cholesterol: Low...............<40 mg/dL Optimal...........>60 mg/dL LDL Cholesterol Direct 50.0 63.0 - 159.0 L SHVRT mg/dL Comment: The National Cholesterol Education Program (NCEP) has set the following guidelines (reference values) for LDL Cholesterol: Optimal.......................<130 mg/dL Borderline High...............130-159 mg/dL High..........................160-189 mg/dL Very High.....................>190 mg/dL HDL/Cholesterol Ratio 25.0 20.0 - 50.0 % — SHVRT Cholesterol/HDL Ratio 4.0 2.0 - 5.0 — SHVRT Non HDL Cholesterol 75 mg/dL — SHVRT Comment: Risk category and Non-HDL cholesterol goals: Coronary heart disease (CHD)or equivalent (10-year risk of CHD >20%): Non-HDL cholesterol goal <130 mg/dL Two or more CHD risk factors and 10-year risk of CHD <= 20%: Non-HDL cholesterol goal <160 mg/dL 0 to 1 CHD risk factor: Non-HDL cholesterol goal <190 mg/dL Generated on 10/30/24 11:39 AM Page 8"
    },
    {
        "page": 9,
        "paragraphs": "OLSC PRV PRIMARY CARE Melvin, William F 1541 Kings Hwy MRN: 14458325, DOB: 9/24/1948, Legal Sex: M SHREVEPORT LA 71103-4228 Acct #: 28009157410 Enc. Date 10/9/2024 Labs (continued) Testing Performed By Lab - Abbreviation Name Director Address Valid Date Range 650 - SHVRT OCHSNER LSU Unknown 1541 Kings Hwy 04/27/23 0824 - Present HEALTH SHREVEPORT LA SHREVEPORT 71103 Indications Type 2 diabetes mellitus with diabetic microalbuminuria, without long-term current use of insulin [E11.29, R80.9 (ICD-10-CM)] CBC Auto Differential [1096741733] (Final result) Electronically signed by: Callegan-Poche, Amanda L., MD on 10/09/24 0834 Status: Completed Ordering user: Callegan-Poche, Amanda L., MD 10/09/24 0834 Authorized by: Callegan-Poche, Amanda L., MD Ordering mode: Standard Frequency: Routine 10/09/24 - Class: Clinic Collect Quantity: 1 Lab status: Final result Diagnoses Type 2 diabetes mellitus with diabetic microalbuminuria, without long-term current use of insulin [E11.29, R80.9] Specimen Information ID Type Source Collected By 24OLSH- Blood Blood 10/09/24 0846 283H0221 CBC Auto Differential [1096741733] CBC with Differential [1180377578] (Abnormal) Resulted: 10/09/24 1926, Result status: Final result Order status: Completed Filed by: Lab, Background User 10/09/24 1926 Collected by: Brown, Shaquerra, CMA 10/09/24 0846 Resulting lab: OCHSNER LSU HEALTH SHREVEPORT Components Reference Component Value Range Flag Lab WBC 8.12 3.90 - 12.70 K/uL — SHVRT RBC 5.07 4.60 - 6.20 M/uL — SHVRT HGB 14.2 12.5 - 16.3 gm/dL — SHVRT HCT 45.1 36.7 - 47.1 % — SHVRT MCV 89 82 - 98 fL — SHVRT MCH 28.0 27.0 - 50.0 pg — SHVRT MCHC 31.5 31.0 - 37.0 g/dL — SHVRT RDW 14.6 11.5 - 14.5 % H SHVRT RDW-SD 47.6 37.5 - 49.0 fL — SHVRT Platelet Count 151 150 - 450 K/uL — SHVRT MPV 11.7 9.2 - 12.9 fL — SHVRT Nucleated RBC 0 <=0 /100 WBC — SHVRT Neut % 62.6 38 - 73 % — SHVRT Lymph % 22.5 18 - 48 % — SHVRT Mono % 8.6 4 - 15 % — SHVRT Eos % 4.1 <=8 % — SHVRT Basophil % 1.6 <=1.9 % — SHVRT Relative Immature Granulocytes 0.6 0.0 - 0.5 % H SHVRT Neut # 5.08 1.8 - 7.7 K/uL — SHVRT Lymph # 1.83 1 - 4.8 K/uL — SHVRT Mono # 0.70 0.3 - 1 K/uL — SHVRT Eos # 0.33 <=0.5 K/uL — SHVRT Baso # 0.13 <=0.2 K/uL — SHVRT Absolute Immature Granulocytes 0.05 0.00 - 0.04 K/uL H SHVRT Comment: Mild elevation in immature granulocytes is non specific and can be seen in a variety of conditions including stress response, acute inflammation, trauma and pregnancy. Correlation with other laboratory and clinical findings is essential. Generated on 10/30/24 11:39 AM Page 9"
    },
    {
        "page": 10,
        "paragraphs": "OLSC PRV PRIMARY CARE Melvin, William F 1541 Kings Hwy MRN: 14458325, DOB: 9/24/1948, Legal Sex: M SHREVEPORT LA 71103-4228 Acct #: 28009157410 Enc. Date 10/9/2024 Labs (continued) Testing Performed By Lab - Abbreviation Name Director Address Valid Date Range 650 - SHVRT OCHSNER LSU Unknown 1541 Kings Hwy 04/27/23 0824 - Present HEALTH SHREVEPORT LA SHREVEPORT 71103 Indications Type 2 diabetes mellitus with diabetic microalbuminuria, without long-term current use of insulin [E11.29, R80.9 (ICD-10-CM)] Microalbumin/creatinine urine ratio [1180377570] (Final result) Electronically signed by: Callegan-Poche, Amanda L., MD on 10/09/24 0834 Status: Completed Ordering user: Callegan-Poche, Amanda L., MD 10/09/24 0834 Authorized by: Callegan-Poche, Amanda L., MD Ordering mode: Standard Frequency: Routine 10/09/24 - Class: Clinic Collect Quantity: 1 Lab status: Final result Diagnoses Type 2 diabetes mellitus with diabetic microalbuminuria, without long-term current use of insulin [E11.29, R80.9] Questionnaire Question Answer Specimen Source Urine Send normal result to authorizing provider's In Basket if patient is Yes active on MyChart: Order comments: Specimen Information ID Type Source Collected By 24OLSH- Urine Urine, Clean Brown, Shaquerra, CMA 283C0338 Catch 10/09/24 0846 Microalbumin/creatinine urine ratio [1180377570] (Abnormal) Resulted: 10/09/24 1952, Result status: Final result Order status: Completed Filed by: Lab, Background User 10/09/24 1952 Collected by: Brown, Shaquerra, CMA 10/09/24 0846 Resulting lab: OCHSNER LSU HEALTH SHREVEPORT Components Component Value Reference Range Flag Lab Urine Microalbumin 10.0 ug/mL — SHVRT Urine Creatinine 33.0 23.0 - 375.0 — SHVRT mg/dL Microalbumin/Creatinine Ratio Urine 30.3 <=30.0 ug/mg H SHVRT Testing Performed By Lab - Abbreviation Name Director Address Valid Date Range 650 - SHVRT OCHSNER LSU Unknown 1541 Kings Hwy 04/27/23 0824 - Present HEALTH SHREVEPORT LA SHREVEPORT 71103 Indications Type 2 diabetes mellitus with diabetic microalbuminuria, without long-term current use of insulin [E11.29, R80.9 (ICD-10-CM)] CBC with Differential [1180377578] (Final result) Generated on 10/30/24 11:39 AM Page 10"
    },
    {
        "page": 11,
        "paragraphs": "OLSC PRV PRIMARY CARE Melvin, William F 1541 Kings Hwy MRN: 14458325, DOB: 9/24/1948, Legal Sex: M SHREVEPORT LA 71103-4228 Acct #: 28009157410 Enc. Date 10/9/2024 Labs (continued) Status: Completed Order placed as a reflex to CBC Auto Differential [1096741733] ordered on 10/09/24 at 0834 Ordering user: Callegan-Poche, Amanda L., MD 10/09/24 0834 Authorized by: Callegan-Poche, Amanda L., MD Ordering mode: Standard Frequency: Routine 10/09/24 - Class: Clinic Collect Quantity: 1 Lab status: Final result Diagnoses Type 2 diabetes mellitus with diabetic microalbuminuria, without long-term current use of insulin [E11.29, R80.9] Specimen Information ID Type Draw Type Source Collected By 24OLSH- Blood Venipuncture Blood Brown, Shaquerra, CMA 283H0221 10/09/24 0846 CBC with Differential [1180377578] (Abnormal) Resulted: 10/09/24 1926, Result status: Final result Order status: Completed Filed by: Lab, Background User 10/09/24 1926 Collected by: Brown, Shaquerra, CMA 10/09/24 0846 Resulting lab: OCHSNER LSU HEALTH SHREVEPORT Components Component Value Reference Range Flag Lab WBC 8.12 3.90 - 12.70 K/uL — SHVRT RBC 5.07 4.60 - 6.20 M/uL — SHVRT HGB 14.2 12.5 - 16.3 gm/dL — SHVRT HCT 45.1 36.7 - 47.1 % — SHVRT MCV 89 82 - 98 fL — SHVRT MCH 28.0 27.0 - 50.0 pg — SHVRT MCHC 31.5 31.0 - 37.0 g/dL — SHVRT RDW 14.6 11.5 - 14.5 % H SHVRT RDW-SD 47.6 37.5 - 49.0 fL — SHVRT Platelet Count 151 150 - 450 K/uL — SHVRT MPV 11.7 9.2 - 12.9 fL — SHVRT Nucleated RBC 0 <=0 /100 WBC — SHVRT Neut % 62.6 38 - 73 % — SHVRT Lymph % 22.5 18 - 48 % — SHVRT Mono % 8.6 4 - 15 % — SHVRT Eos % 4.1 <=8 % — SHVRT Basophil % 1.6 <=1.9 % — SHVRT Relative Immature Granulocytes 0.6 0.0 - 0.5 % H SHVRT Neut # 5.08 1.8 - 7.7 K/uL — SHVRT Lymph # 1.83 1 - 4.8 K/uL — SHVRT Mono # 0.70 0.3 - 1 K/uL — SHVRT Eos # 0.33 <=0.5 K/uL — SHVRT Baso # 0.13 <=0.2 K/uL — SHVRT Absolute Immature Granulocytes 0.05 0.00 - 0.04 K/uL H SHVRT Comment: Mild elevation in immature granulocytes is non specific and can be seen in a variety of conditions including stress response, acute inflammation, trauma and pregnancy. Correlation with other laboratory and clinical findings is essential. Testing Performed By Lab - Abbreviation Name Director Address Valid Date Range 650 - SHVRT OCHSNER LSU Unknown 1541 Kings Hwy 04/27/23 0824 - Present HEALTH SHREVEPORT LA SHREVEPORT 71103 Indications Type 2 diabetes mellitus with diabetic microalbuminuria, without long-term current use of insulin [E11.29, R80.9 (ICD-10-CM)] Generated on 10/30/24 11:39 AM Page 11"
    },
    {
        "page": 12,
        "paragraphs": "OLSC PRV PRIMARY CARE Melvin, William F 1541 Kings Hwy MRN: 14458325, DOB: 9/24/1948, Legal Sex: M SHREVEPORT LA 71103-4228 Acct #: 28009157410 Enc. Date 10/9/2024 Labs (continued) Follow-up and Disposition History 10/09/2024 0843 - Amanda L. Callegan-Poche, MD Dispositions: · Follow up in about 6 months (around 4/9/2025). Follow-up Information None Follow Up Call No data filed END OF REPORT Generated on 10/30/24 11:39 AM Page 12"
    }
]